Status:
NOT_YET_RECRUITING
Polyuria Associated With Dexmedetomidine in Operating Room
Lead Sponsor:
Hospital Privado de Comunidad de Mar del Plata
Conditions:
Polyuria
Eligibility:
All Genders
18-90 years
Brief Summary
Dexmedetomidine is an a2-adrenergic receptor agonist drug, widely used in intensive care for the sedation of patients on mechanical ventilation, as well as in the operating room during invasive proced...
Detailed Description
This is a prospective, observational study designed to determine the incidence of polyuria, defined as urine output greater than 150 ml/h or 3 ml/kg/h, associated with the administration of dexmedetom...
Eligibility Criteria
Inclusion
- Age \> 18 years old
- Scheduled surgery
- Dexmedetomidine in boluses and/or continuous infusion during intra-operative period
- Patients who require arterial line and urinary catheter
Exclusion
- Chronic renal disease.
- eGFR \< 60 ml/min/1.73m2 for more than 3 months of evolution.
- Emergency or unscheduled surgeries.
- Central nervous system disease at the sellar or suprasellar level.
- Patients receiving diuretics.
- Liver cirrhosis.
- Adrenal gland disease.
Key Trial Info
Start Date :
August 10 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 10 2025
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06535386
Start Date
August 10 2024
End Date
January 10 2025
Last Update
August 7 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.